Our Science

Brilliant scientists. Advanced technology. Targeted human genetics. Precision chemistry. It all comes together at Eisai to improve health care.

TAKE AN IN-DEPTH LOOK AT OUR PIPELINE

TAKE AN IN-DEPTH LOOK AT OUR PIPELINE

We’re rapidly developing innovative solutions to meet some of society’s most difficult health care challenges.

Find out why we’re so focused on Neurology and Oncology

Find out why we’re so focused on Neurology and Oncology

And learn how we’re spearheading work in immuno-oncology, dementia and Alzheimer’s disease treatments, sleep-wake rhythm disorder, epilepsy therapies and more.

30+

That’s how many years we’ve been investing our research dollars — and our hearts and souls — in Neurology and Oncology R&D.

Learn about clinical trials that could lead to breakthroughs

Learn about clinical trials that could lead to breakthroughs

We’re evaluating potential new therapies for a variety of cancers and neurological disorders.

Discover new frontiers of Neurology and Oncology science

Discover new frontiers of Neurology and Oncology science

We’ve established three Discovery Centers, each with its own bold approach to pushing the boundaries of science in search of life-changing solutions.

DID WE MENTION OUR THREE AMAZING DISCOVERY CENTERS?

We're rapidly developing breakthrough solutions to address some of the world's greatest unmet medical needs.

EISAI CENTER FOR GENETICS GUIDED DEMENTIA DISCOVERY (G2D2)

EISAI CENTER FOR GENETICS GUIDED DEMENTIA DISCOVERY (G2D2)

G2D2 combines human genetics, data sciences and precision chemistry to disrupt the traditional drug discovery paradigm. This science-first organization has one goal: to deliver breakthroughs for dementia patients and their families.

CONTACT G2D2:35 Cambridgepark Drive, Cambridge, MA 02140, United States | P: 857.829.6100

H3 BIOMEDICINE (H3)

H3 BIOMEDICINE (H3)

H3 is a leader in cancer genomics-based drug discovery, delivering on the promise of precision medicine. H3 scientists are creating novel therapies with the potential to improve the lives of patients living with cancer.

CONTACT H3: 300 Technology Square, FL 5, Cambridge, MA 02139, United States | P: 617.252.5000

EPOCHAL PRECISION ANTI-CANCER THERAPEUTICS (EPAT)

EPOCHAL PRECISION ANTI-CANCER THERAPEUTICS (EPAT)

EPAT focuses on oncology drug development utilizing our unique Antibody-Drug Conjugate (ADC) technology, bispecifics and other emerging biologics. EPAT’s precision medicine and diagnostics aim to improve therapeutic results with fewer side effects.

CONTACT EPAT: 210 Welsh Pool Road, Exton, PA 19341, United States | P: 610-423-6100